TP53 and squamous cell carcinoma: In lung cancer, TP53 represents the most frequently mutated gene, occurring in over half of adenocarcinoma, 80% of squamous cell carcinoma and 70% of small-cell-lung cancer [15], and, despite debated [28], it has been suggested as an independent marker for shorter survival in advanced NSCLC.